Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Physiological Pharmacokinetic Models: Assumption with Protein Binding01:13

Physiological Pharmacokinetic Models: Assumption with Protein Binding

91
Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
91
The Two-State Receptor Model01:29

The Two-State Receptor Model

2.4K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
2.4K
Conserved Binding Sites01:49

Conserved Binding Sites

4.3K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.3K
The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

13.4K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
13.4K
Ligand Binding Sites02:40

Ligand Binding Sites

13.1K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
13.1K
Protein-Drug Binding: Mechanism and Kinetics01:16

Protein-Drug Binding: Mechanism and Kinetics

924
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
924

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Energy substrate preference and metabolic flexibility in quiescent and oxytocin-stimulated human myometrial cells.

iScience·2026
Same author

African American Food Environments and Anti-Inflammatory Intake in Pregnancy.

International journal of environmental research and public health·2026
Same author

Effects of Maternal Obesity on Fetal Cerebral Glucose Transporter Expression.

bioRxiv : the preprint server for biology·2026
Same author

Atherogenic index of plasma as a predictor of cardiovascular outcomes in patients with myocardial infarction with nonobstructive coronary arteries.

Scientific reports·2026
Same author

Multi-Scale Temporal Coordinate Attention Network with Peak-Aware Mechanism for Rolling Bearing Fault Diagnosis Under Low Signal-to-Noise Ratio Conditions.

Sensors (Basel, Switzerland)·2026
Same author

A cryptic-site ligand stabilizes a non-canonical interface and blocks membrane insertion of the chloride intracellular channel CLIC1.

The Journal of biological chemistry·2026

Related Experiment Video

Updated: Sep 9, 2025

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
08:04

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Published on: June 6, 2025

492

Predicting oxytocin binding dynamics in receptor genetic variants through computational modeling.

Preeti Dubey1, Yingye Fang1, K Lionel Tukei1

  • 1Department of Bioengineering, University of Washington, Seattle, WA, USA.

Npj Women'S Health
|August 29, 2025
PubMed
Summary

This study models how oxytocin receptor (OXT) genetic variants affect drug response. Mathematical modeling offers a framework for personalized Pitocin dosing in pregnant individuals.

More Related Videos

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
06:50

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions

Published on: January 26, 2024

2.0K
Author Spotlight: Evaluation of Protein-Condensate Dynamics in Live Human Cells
06:48

Author Spotlight: Evaluation of Protein-Condensate Dynamics in Live Human Cells

Published on: January 5, 2024

4.1K

Related Experiment Videos

Last Updated: Sep 9, 2025

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
08:04

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Published on: June 6, 2025

492
Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
06:50

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions

Published on: January 26, 2024

2.0K
Author Spotlight: Evaluation of Protein-Condensate Dynamics in Live Human Cells
06:48

Author Spotlight: Evaluation of Protein-Condensate Dynamics in Live Human Cells

Published on: January 5, 2024

4.1K

Area of Science:

  • Pharmacogenomics
  • Molecular Pharmacology
  • Computational Biology

Background:

  • Pitocin (synthetic oxytocin) is widely used but optimal dosing is difficult due to patient variability.
  • Genetic variations in the oxytocin receptor (OXTR) may influence individual responses to oxytocin.
  • Understanding these genetic influences is crucial for improving obstetric care.

Purpose of the Study:

  • To develop a mathematical model simulating oxytocin (OXT) and oxytocin receptor (OXTR) binding dynamics.
  • To investigate the impact of five specific OXTR genetic variants on OXT-OXTR interactions.
  • To explore how these variants affect OXT response in different cell types.

Main Methods:

  • Developed a mathematical model of OXT-OXTR binding dynamics.
  • Incorporated experimentally measured, cell-specific OXTR surface localization data.
  • Utilized literature-reported OXT-OXTR binding kinetics for model parameterization.
  • Simulated OXT-OXTR interactions in human embryonic kidney (HEK293T) and myometrial smooth muscle cells.

Main Results:

  • The model identified differences in OXT-OXTR binding equilibrium times between HEK293T and myometrial cells.
  • Distinct binding dynamics were observed across the five studied OXTR genetic variants.
  • Early OXT administration showed potential to mitigate reduced responses in V281M and E339K variants.

Conclusions:

  • Genetic variants in OXTR significantly influence OXT dose-response relationships.
  • The developed mathematical model provides insights into OXT pharmacodynamics at a genetic level.
  • This framework can potentially guide personalized Pitocin dosing strategies based on patient genetic profiles.